Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Knowing when to consider a financial advisor can make a difference in achieving your financial goals. Be proactive in your planning.
26,299 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
PTIR's double-leveraged bet on Palantir underperformed the stock by nearly half over the past year, underscoring the ...
Paysign's 2025 earnings paint a picture of a niche fintech player balancing steady card-services revenue with new par...
A fresh take on dine brands (din) 2025, focusing on Q4 signals, brand momentum, and how investors can position themse...
A single, powerful driver could unlock a dramatic March for Netflix. Learn the core monetization lever and what inves...
AI’s endless appetite for compute and memory is shifting demand away from PCs. Prices rise, supply tightens, and inve...
U.S. short-term yields spike again, pushing traders toward the SGOV ETF for cash-like income with minimal duration ri...
Investors are watching Modine for clues on growth in HVAC and thermal solutions. This guide breaks down the modine (m...
As AI enthusiasm cools, investors pivot to hard assets. New data show demand data center power rising faster than exp...
A single-session drop in the 3X leveraged FNGU ETN trimmed a $10,000 bet to $8,392, illustrating how tech leverage ca...
Overnight market moves spotlight the role of E-Mini futures in price discovery and risk management. This story explai...
When the Fed holds rates, investors often look to the next move. But for Costco stock, a steady policy backdrop may b...